Background The interpretation of changes in serum human chorionic gonadotropin (hCG) concentrations in early pregnancy requires a knowledge of the day-to-day imprecision of the method at the concentrations measured. We therefore attempted to determine the analytical imprecision of our total hCG method over a 4-week period at concentrations up to 20 000 IU/L.
Introduction
Serum human chorionic gonadotropin (hCG) measurements are used in the diagnosis and monitoring of problems in early pregnancy. Interpretation of changes in serum hCG concentrations requires a knowledge of the analytical imprecision of the method used at the concentrations measured. As the hCG concentration in our highest internal quality control material was only 180 IU/L we decided to study the reproducibility of total hCG measurements over a 4-week period using clinical specimens with hCG concentrations up to 20 000 IU/L.
Methods
Thirty-three serum specimens collected during early pregnancy with an hCG concentration between 100 and 20 000 IU/L were each divided into ¢ve aliquots (four for storage at 7208C and the ¢fth at +48C). Total hCG was measured at weekly intervals on the Bayer Advia Centaur immunoassay analyser. The coe⁄cient of variation (CV) for each specimen was calculated from the ¢ve repeat measurements. The signi¢cance of changes in measured hCG concentration with time was assessed using the Wilcoxon Signed Ranks test. The Mann^Whitney U Test was used to assess apparent di¡erences in the behaviour of clinical specimens and quality control materials.
Results
The reproducibility of hCG results below 1000 IU/L (n ¼18) over 4 weeks was poor. The mean CV for refrigerated specimens with an initial hCG concentration in this range was 17.4% (range 13.3^29.7%). The mean CV for specimens stored at 7208C was 9.3% (range 2.6^21.5%).
Short Report
Above 1000 IU/L, precision was better (mean CV for refrigerated specimens 5.0%, range 3.1^8.0%; mean CV for frozen specimens 5.7%, range 3.1^13.2%). The high CVs were related to an increase in measured hCG concentrations in most specimens during storage. The mean increase for refrigerated samples with an initial hCG concentration below 1000 IU/L was 52.5% (range 26.9^67.8) and for frozen specimens was 25% (74.3 to 64.1%).
Using the Wilcoxon Signed Ranks Test (two-tailed), the increase between the initial result and all subsequent time points was statistically signi¢cant for both refrigerated (P40.0008) and frozen samples (P40.007) in specimens with initial hCG results less than 1000 IU/L. Refrigerated samples with initial hCG concentrations below 1000 IU/L also showed statistically signi¢cant increases during the second and third weeks of storage. Figure 1 summarizes the changes observed in refrigerated specimens with initial hCG concentrations 51000 IU/L, specimens with higher hCG concentrations and our Biorad 3 control material.
As a result of these ¢ndings, we collected a further eight specimens with initial hCG concentrations between 17 and 1000 IU/L and measured the hCG concentration after 1, 4 and 7 days' storage at +48C. The results were consistent with the experiment described above, with a mean increase of 5.3% at 24 h, 21% on day 4 and 31% on day 7.
These changes are unlikely to be due to evaporation, as specimens with hCG concentrations above 2000 IU/L were not a¡ected. Furthermore, the day-today coe⁄cient of variation for Biorad 3 was 5.0% and a clinical specimen with an initial hCG concentration of 30 000 IU/L diluted to 600 IU/L gave a day-to-day CV of 2.8%. Thus, our ¢ndings cannot be explained by poor analytical imprecision.
Conclusions
We set out to investigate the day-to-day reproducibility of serum hCG measurements, but appear to have uncovered a stability problem a¡ecting the measurement of hCG in early pregnancy serum samples by our assay. In specimens with an initial hCG concentration below approximately 1000 IU/L, hCG results can be expected to increase with time when the current Bayer Centaur Total hCG assay is used. This may be clinically important if there is a delay in analysis (for example, if specimens are sent through the post or repeat analysis is requested on a stored specimen), especially if small changes in hCG concentration are used to guide patient management. Bayer have recently released a technical bulletin which reiterates the recommendation provided with the method that specimens should be stored frozen if not analysed within 48 h. 1 However, our data suggest this may not be adequate and that specimens should be analysed on the day of collection whenever possible.
The problem is likely to be caused by a change in the conformation of hCG during storage, increasing its immunoreactivity in the Centaur assay. Non-nicked intact hCG is thought to be stable in serum, but nicked hCG dissociates more rapidly, leading to increased free b-subunit concentrations. 2 Data for antibody crossreactivity supplied by Bayer suggests this is unlikely to be the cause as free b-subunit is detected slightly less e⁄ciently than non-nicked and nicked intact hCG. As the e¡ect is most marked when hCG is present in concentrations lower than 1000 IU/L, we suggest the problem may be due to conformational changes in hyperglycosylated hCG, which forms a greater proportion of total hCG in early pregnancy.
Data from UKNEQAS have for some time suggested that between-laboratory agreement for the Bayer Total Mann-Whitney U test. The differences between the two groups of specimens are also statistically significant (P values between 0.0002 and 0.0008).
hCG assays is worse than for most other methods, the ACS 180 and ADVIA Centaur assays being the only methods with between-laboratory CVs consistently 410% at concentrations between 102 and 610 IU/L (quoted with permission). 3, 4 Our observations are consistent with the results of an experiment recently performed by UKNEQAS, which showed a positive correlation between time delay before analysis and reported hCG concentration with the method. 5 Although we appear to have demonstrated a problem a¡ecting the Bayer Centaur Total hCG assay, changes in the conformation of peptides or proteins during specimen storage may also a¡ect other immunoassay platforms.
